Skip to content
10-Q

Quarterly Report

Protagenic Therapeutics, Inc.new PTIX

0001493152-25-025201

← back to feed
Filed
Nov 26, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Nov 26, 2025 1.93M sh
Stock Issued Q2 2026 · Sep 30, 2025 51.2K sh
Shares Diluted Q2 2026 · Sep 30, 2025 1.85M sh
Shares Diluted Q2 2026 · Sep 30, 2025 2.75M sh
Shares Diluted Q2 2026 · Sep 30, 2024 5.4M sh
Shares Diluted Q2 2026 · Sep 30, 2024 5.4M sh
Operating Cash Flow Q2 2026 · Sep 30, 2025 −$2.56M
Operating Cash Flow Q2 2026 · Sep 30, 2024 −$563.87K
Stockholders Equity Q2 2026 · Sep 30, 2025 −$4.7M
Stockholders Equity Q2 2026 · Jun 30, 2025 −$3.97M
Stockholders Equity Q2 2026 · Mar 31, 2025 −$4.95M
Stockholders Equity Q2 2026 · Sep 30, 2024 −$2.47M
Stockholders Equity restated Q2 2026 · Jun 30, 2024 −$1.75M
Stockholders Equity restated Q2 2026 · Mar 31, 2024 −$1.79M
Current Liabilities Q2 2026 · Sep 30, 2025 $9.7M
Current Liabilities Q2 2026 · Mar 31, 2025 $5.04M
Total Liabilities Q2 2026 · Sep 30, 2025 $9.7M
Total Liabilities Q2 2026 · Mar 31, 2025 $5.04M
Current Assets Q2 2026 · Sep 30, 2025 $2.86M
Current Assets Q2 2026 · Mar 31, 2025 $89.09K
Total Assets Q2 2026 · Sep 30, 2025 $5M
Total Assets Q2 2026 · Mar 31, 2025 $89.09K
Eps Diluted Q2 2026 · Sep 30, 2025 −$0.47
Eps Diluted Q2 2026 · Sep 30, 2025 −$2.16
Eps Diluted Q2 2026 · Sep 30, 2024 −$0.11
Eps Diluted Q2 2026 · Sep 30, 2024 −$0.17
Eps Basic Q2 2026 · Sep 30, 2025 −$0.47
Eps Basic Q2 2026 · Sep 30, 2025 −$2.16
Eps Basic Q2 2026 · Sep 30, 2024 −$0.11
Eps Basic Q2 2026 · Sep 30, 2024 −$0.17
Sga Expense Q2 2026 · Sep 30, 2025 $159.92K
Sga Expense Q2 2026 · Sep 30, 2025 $335.13K
Sga Expense Q2 2026 · Sep 30, 2024 $22.03K
Sga Expense Q2 2026 · Sep 30, 2024 $45.77K
Rd Expense Q2 2026 · Sep 30, 2025 $273.23K
Rd Expense Q2 2026 · Sep 30, 2025 $667.34K
Rd Expense Q2 2026 · Sep 30, 2024 $16.96K
Rd Expense Q2 2026 · Sep 30, 2024 $36.1K
Net Income Q2 2026 · Sep 30, 2025 −$869.5K
Net Income Q2 2026 · Sep 30, 2025 −$5.93M
Net Income Q2 2026 · Jun 30, 2025 −$5.06M
Net Income Q2 2026 · Sep 30, 2024 −$582.39K
Net Income Q2 2026 · Sep 30, 2024 −$906.74K
Net Income restated Q2 2026 · Jun 30, 2024 −$324.36K
Operating Income Q2 2026 · Sep 30, 2025 −$1.11M
Operating Income Q2 2026 · Sep 30, 2025 −$3.46M
Operating Income Q2 2026 · Sep 30, 2024 −$355.37K
Operating Income Q2 2026 · Sep 30, 2024 −$677.21K
Revenue Q2 2026 · Sep 30, 2025 $0